Abstracts - Rules
Submission rules
Content rules
Submission Rules
1. Abstracts will not be accepted unless they are submitted
online via the online abstract submission system before midnight
(GMT), 15th May 2010. Late abstracts will NOT be accepted.
Abstracts submitted by post, fax or email will not be considered.
2. All abstracts should be written, submitted and presented
in English with a maximum word count of 250 words (not including
the abstract title, authors and institutions).
3. All correspondence will be sent to the submitting author
only. It is the responsibility of the submitting author to forward
any
relevant correspondence to the presenting author.
4. Each author is permitted to present once (not including invited
lectures).
5. Authors will be notified in writing in June 2010 whether
or not their abstract has been approved by the Scientific Advisory
Committee (SAC). The decision of the SAC is final and no correspondence
will be entered into.
6. Once an abstract has been approved, the presenting author
must register for the Congress for final acceptance. Abstracts
will
only receive final acceptance if the presenting author has registered
for the entire Congress. Day registrations will not be permitted.
7. All presenting authors are expected to attend the congress.
Non-registered presenting authors may be excluded from publication
in the congress final programme.
8. Instructions for both platform and poster presentations will
be available on the congress website. Abstracts selected for
oral presentations may use either Microsoft PowerPoint (PC Format)
or standard VHS video only.
Content rules
1. Abstract submitters should ensure that the version sent is
the final one, changes will not be permitted.
2. Institution information should be provided for all authors.
Including institution, city, state/province and country but
excluding department, division, laboratory, etc.
3. Category: please select the category from the list displayed
in the drop down menu.
- Aspectos Sociales/Social Issues
- Calidad De Vida/Quality Of Life
- Causas De La Epilepsia/Causes Of Epilepsy
- Cirugía/Surgery
- Consecuencias De La Epilepsia/Outcome Of Epilepsy
- Costes De La Epilepsia/Cost Of Epilepsy
- Epidemiología/Epidemiology
- Epilepsia En La Infancia/Epilepsy In Early Childhood
- Epilepsia En La Mujer/Epilepsy And Women
- Epilepsia En Tercera Edad/Epilepsy In The Elderly
- Epilepsia Refractaria/Refractory Epilepsy
- Epilepsia Y Sueño/Epilepsy And Sleep
- Farmacología/Pharmacology
- Genética/Genetics
- Neurobiología/Neurobiology Prevención/Prevention
- Tratamiento/Treatment
4. Abstracts should be structured in 4 sections:
1. Purpose 2. Method 3. Results 4. Conclusion
The "Purpose" section should indicate the objectives
of the work being presented. The "Method" section should
describe study material or subjects (e.g. number and type of patients),
intervention and evaluation procedures. The "Results" section
should summarise the main findings. Wherever possible, give numerical
values, including means with SD or SEM, and statistical significance
or confidence intervals. The "Conclusion" section should
state briefly the conclusions reached in the work.
Figures, tables and other illustrations can not be included.
5. If the work was supported by funds provided by a commercial
organisation this should be stated in a short acknowledgment at
the end of the abstract. Other sources of funding may be acknowledged
in the same way.
6. Submission of abstracts describing data that have previously
been published in any scientific journal is not permitted.
7. Multiple submissions of abstracts describing different components
of the same study is not appropriate. All findings generated from
the same study should be included in a single abstract.
8. Abstracts containing single case reports will not usually be
accepted, unless the report is of outstanding scientific or clinical
interest because of the uniqueness of the findings or the sophistication
of the investigations.
9. Abstracts containing data considered to be insufficiently informative
will not be accepted.
10. Authors should use a concise title that indicates the content
of the abstract. The title should not exceed 240 characters. Abbreviations
should be avoided in the title.
11. For intervention studies (for example, therapeutic trials),
type of design (prospective or retrospective, controlled or uncontrolled,
randomised or observational, open vs. single-blind vs. double-blind),
dosages, assessment methods and duration of follow-up should be
specified.
12. Non-proprietary names of drugs must be used throughout. If
results are considered to be specific for a given proprietary
product (for example, bio-equivalence studies), the non-proprietary
name must still be used, followed by the proprietary name and
the name of the manufacturers in brackets.
13. Abbreviations should be used sparingly. For words that are
abbreviated, use the whole term the first time, followed by the
standard abbreviation in parenthesis. For anti-epileptic drugs,
standard abbreviations are those published in Epilepsia 1993;
34:1151.
14. References should be used sparingly. They should be included
within the text in brackets. For journals, mention first author "et
al" followed by the name of the journal as abbreviated in
the Index Medicus, year, volume number and inclusive pages (i.e.
Hardus P et al. Epilepsia 2001;42:262-267.). For book chapters,
give first author "et
al", editor, title, publisher,
city of publication, year and inclusive pages (i.e. Levy RH et
al. In: Levy RH et al, Antiepileptic Drugs. Lippincott-Raven,
1996;13-30.)
15. Submission of an abstract automatically implies acknowledgment
that the work described was conducted in accordance with current
ethical standards and regulations in biomedical research. Failure
to adhere to these standards will result in rejection of the abstract.
